The flu shot may not protect
pediatric leukemia patients from influenza during cancer treatment, highlighting the need for additional safeguards.
St. Jude Children's Research Hospital leads study showing that a drug withdrawn from the market in 2010 may enhance the effectiveness of bone marrow transplants for select
pediatric leukemia patients
Not exact matches
The company's lead product candidate, dilanubicel (NLA101), is currently being evaluated in two ongoing Phase 2 clinical trials in adult and
pediatric patients with hematologic malignancies undergoing an allogeneic transplant and adult
patients receiving high dose chemotherapy for Acute Myeloid
Leukemia.
«This condition is one of the main reasons that many bone marrow transplant
patients endure long hospital stays after their diseases are cured,» said Kean, who wears a bracelet around her badge from a
pediatric patient cured of
leukemia one year ago, but is still in the hospital due to complications from GVHD.
Seattle Childrens» press release says that Kean wears a bracelet around her badge from a
pediatric patient cured of
leukemia one year ago, but who is still in the hospital due to complications from graft - vs - host.
The FDA approved gemtuzumab ozogamicin (Mylotarg), an anti-CD33 antibody - drug conjugate, for adult and
pediatric patients with relapsed CD33 - positive acute myeloid
leukemia (AML) as well as adults with newly diagnosed CD33 - positive AML.
Removal of a fifth course of chemotherapy containing cytarabine resulted in worse overall survival and disease - free survival in
pediatric patients with low - risk acute myeloid
leukemia (AML), according to the results (abstract 10515) of a pooled analysis of two Children's Oncology Group (COG) trials presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 — 6 in Chicago.
The use of minimal residual disease (MRD) provided a more objective measure of induction failure in
patients with
pediatric acute lymphoblastic
leukemia (ALL) than did morphology, according to the results of a study published recently in the Journal of Clinical Oncology.
A phase I / II trial of genetically modified T cells directed against CD19 for
pediatric and young adult
patients with relapsed / refractory CD19 +
leukemia (NCT02028455).
Whole genome and whole transcriptome sequencing of 31
pediatric Asian
patients with T - cell acute lymphoblastic
leukemia found that about 10 percent had the same alteration in a non-coding region of DNA.
Arsenic trioxide (ATO) consolidation was well tolerated in
pediatric patients with acute promyelocytic
leukemia (APL) and allowed for significant reductions in cumulative anthracycline doses, according to the results of the Children's Oncology Group AAML0631 trial published in the Journal of Clinical Oncology.
Arsenic trioxide consolidation was well tolerated in
pediatric patients with acute promyelocytic
leukemia and allowed for significant reductions in cumulative anthracycline doses.
The 101 medical malpractice lawsuits reportedly arose in 1998 after university hospital officials disclosed that many
pediatric oncology
patients were likely not provided with the newest or most effective treatment for acute lymphoblastic
leukemia during a seven - year period.